News
HealthDay on MSN
Daily Aspirin Cuts Colon Cancer Recurrence Risk By Half
Key Takeaways Daily aspirin can cut in half the risk that colon cancer will come backRisk of recurrence was 55% lower in ...
15hon MSN
Aspirin halves the risk of recurrence in patients with colorectal cancer, clinical trial finds
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized ...
GB News on MSN
Scientists hail 'huge effect' of daily pill that slashes risk of colon cancer returning by 55%
A groundbreaking Swedish study has demonstrated that taking aspirin daily can slash the likelihood of colorectal cancer ...
This page was updated Sept. 12, 2023, to add data for 2015 through 2019 that was released as part of a court case. For the first time, Americans can see the rise — and fall — of legal opioids entering ...
After rejecting ImmunityBio’s Anktiva last year, the FDA has cleared the drug as a treatment for bladder cancer, making it the company’s first commercial-stage product. Anktiva (nogapendekin alfa ...
MoonLake Immunotherapeutics has secured up to $500 million in non-dilutive financing from Hercules Capital, bolstering its cash reserves as it ushers its lead drug for inflammatory diseases through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results